 Todd Getz
Concepts (162)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Blood Platelets | 18 | 2022 | 390 | 4.380 |
Why?
| | Blood Preservation | 7 | 2022 | 300 | 1.900 |
Why?
| | Cryopreservation | 3 | 2022 | 109 | 1.290 |
Why?
| | Platelet Aggregation | 6 | 2020 | 91 | 1.270 |
Why?
| | Intracellular Signaling Peptides and Proteins | 3 | 2013 | 406 | 0.830 |
Why?
| | Hemostasis | 4 | 2018 | 61 | 0.780 |
Why?
| | Suntan | 1 | 2019 | 1 | 0.760 |
Why?
| | Protein-Tyrosine Kinases | 3 | 2013 | 448 | 0.760 |
Why?
| | Platelet Transfusion | 2 | 2020 | 66 | 0.760 |
Why?
| | Platelet Membrane Glycoproteins | 5 | 2013 | 47 | 0.710 |
Why?
| | Bleeding Time | 2 | 2015 | 4 | 0.600 |
Why?
| | Saphenous Vein | 2 | 2015 | 37 | 0.580 |
Why?
| | Vascular System Injuries | 1 | 2015 | 56 | 0.530 |
Why?
| | Receptors, Thrombin | 2 | 2013 | 14 | 0.530 |
Why?
| | Dextran Sulfate | 1 | 2013 | 72 | 0.490 |
Why?
| | Blood Coagulation | 4 | 2019 | 216 | 0.480 |
Why?
| | Threonine | 2 | 2010 | 51 | 0.440 |
Why?
| | Blood Component Removal | 2 | 2022 | 33 | 0.420 |
Why?
| | Phosphatidylinositol 3-Kinases | 1 | 2013 | 358 | 0.420 |
Why?
| | Flow Cytometry | 5 | 2019 | 1167 | 0.420 |
Why?
| | Myosin Light Chains | 1 | 2010 | 34 | 0.420 |
Why?
| | Carbazoles | 1 | 2011 | 95 | 0.410 |
Why?
| | Plateletpheresis | 3 | 2022 | 30 | 0.410 |
Why?
| | Serine | 1 | 2010 | 130 | 0.400 |
Why?
| | Apoptosis | 1 | 2019 | 2616 | 0.360 |
Why?
| | Platelet Activation | 6 | 2015 | 63 | 0.340 |
Why?
| | Cold Temperature | 2 | 2020 | 158 | 0.330 |
Why?
| | Thromboplastin | 2 | 2015 | 34 | 0.290 |
Why?
| | Reactive Oxygen Species | 2 | 2019 | 559 | 0.280 |
Why?
| | Syk Kinase | 3 | 2013 | 18 | 0.260 |
Why?
| | Lectins, C-Type | 3 | 2013 | 72 | 0.260 |
Why?
| | Thrombosis | 2 | 2015 | 278 | 0.220 |
Why?
| | Ticlopidine | 3 | 2015 | 76 | 0.200 |
Why?
| | Mice, Knockout | 7 | 2018 | 2835 | 0.200 |
Why?
| | Quinolines | 1 | 2020 | 140 | 0.190 |
Why?
| | Factor IX | 2 | 2018 | 8 | 0.190 |
Why?
| | Platelet Count | 1 | 2019 | 86 | 0.190 |
Why?
| | Hemostatics | 1 | 2019 | 43 | 0.180 |
Why?
| | Isoenzymes | 2 | 2011 | 356 | 0.180 |
Why?
| | Factor IXa | 1 | 2018 | 1 | 0.180 |
Why?
| | Protein S | 1 | 2018 | 7 | 0.180 |
Why?
| | Hemophilia B | 1 | 2018 | 14 | 0.170 |
Why?
| | Protein Kinase C | 2 | 2011 | 349 | 0.170 |
Why?
| | Hydrogen-Ion Concentration | 1 | 2019 | 582 | 0.160 |
Why?
| | Lactic Acid | 1 | 2019 | 295 | 0.160 |
Why?
| | Platelet Aggregation Inhibitors | 3 | 2015 | 397 | 0.160 |
Why?
| | Calcium | 3 | 2013 | 1208 | 0.160 |
Why?
| | Heparin | 1 | 2018 | 226 | 0.150 |
Why?
| | Platelet Glycoprotein GPIIb-IIIa Complex | 1 | 2016 | 25 | 0.150 |
Why?
| | Refrigeration | 1 | 2016 | 10 | 0.150 |
Why?
| | Venous Thrombosis | 1 | 2018 | 133 | 0.150 |
Why?
| | Humans | 19 | 2022 | 115146 | 0.140 |
Why?
| | Solutions | 1 | 2016 | 187 | 0.140 |
Why?
| | rap1 GTP-Binding Proteins | 1 | 2015 | 7 | 0.140 |
Why?
| | Platelet Glycoprotein GPIb-IX Complex | 1 | 2015 | 3 | 0.140 |
Why?
| | Talin | 1 | 2015 | 8 | 0.140 |
Why?
| | Platelet Adhesiveness | 1 | 2015 | 13 | 0.140 |
Why?
| | Microscopy, Video | 1 | 2015 | 24 | 0.140 |
Why?
| | Cell-Derived Microparticles | 1 | 2015 | 62 | 0.140 |
Why?
| | Intravital Microscopy | 1 | 2015 | 19 | 0.140 |
Why?
| | Mice, Inbred C57BL | 5 | 2018 | 5151 | 0.140 |
Why?
| | GTPase-Activating Proteins | 1 | 2015 | 67 | 0.140 |
Why?
| | Fibrin | 1 | 2015 | 53 | 0.140 |
Why?
| | Fibrinogens, Abnormal | 1 | 2014 | 4 | 0.140 |
Why?
| | Skin | 1 | 2019 | 680 | 0.130 |
Why?
| | Phosphorylation | 4 | 2013 | 1734 | 0.130 |
Why?
| | Laser Therapy | 1 | 2015 | 94 | 0.130 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2019 | 2187 | 0.130 |
Why?
| | Glucose | 1 | 2019 | 909 | 0.130 |
Why?
| | Mitochondria | 2 | 2019 | 819 | 0.130 |
Why?
| | Crotalid Venoms | 2 | 2011 | 33 | 0.130 |
Why?
| | Peptides, Cyclic | 2 | 2013 | 261 | 0.120 |
Why?
| | Fibrinogen | 1 | 2014 | 155 | 0.120 |
Why?
| | Bacteria | 1 | 2019 | 661 | 0.120 |
Why?
| | Microscopy, Fluorescence | 1 | 2015 | 434 | 0.120 |
Why?
| | Signal Transduction | 5 | 2013 | 4905 | 0.120 |
Why?
| | Polysaccharides | 1 | 2013 | 82 | 0.120 |
Why?
| | Arteries | 1 | 2014 | 236 | 0.120 |
Why?
| | Animals | 11 | 2018 | 34755 | 0.110 |
Why?
| | Tyrosine | 1 | 2013 | 241 | 0.110 |
Why?
| | Mice | 9 | 2015 | 15478 | 0.110 |
Why?
| | Protein Binding | 2 | 2018 | 2056 | 0.110 |
Why?
| | Blood Vessels | 1 | 2013 | 191 | 0.110 |
Why?
| | Cell Shape | 1 | 2010 | 54 | 0.100 |
Why?
| | Peptides | 3 | 2011 | 865 | 0.100 |
Why?
| | Adenosine Diphosphate | 1 | 2010 | 92 | 0.100 |
Why?
| | Cells, Cultured | 1 | 2019 | 4291 | 0.100 |
Why?
| | Membrane Glycoproteins | 1 | 2013 | 495 | 0.100 |
Why?
| | Time Factors | 3 | 2020 | 7041 | 0.100 |
Why?
| | rho-Associated Kinases | 1 | 2010 | 86 | 0.100 |
Why?
| | Amino Acids, Aromatic | 1 | 2009 | 8 | 0.100 |
Why?
| | Collagen Type IV | 1 | 2009 | 23 | 0.100 |
Why?
| | Kinetics | 2 | 2010 | 1759 | 0.100 |
Why?
| | Protein Tyrosine Phosphatases | 1 | 2010 | 139 | 0.090 |
Why?
| | Energy Metabolism | 1 | 2016 | 930 | 0.090 |
Why?
| | Carrier Proteins | 2 | 2011 | 806 | 0.090 |
Why?
| | Calcium Signaling | 1 | 2011 | 226 | 0.090 |
Why?
| | In Vitro Techniques | 1 | 2011 | 1231 | 0.090 |
Why?
| | Disease Models, Animal | 2 | 2018 | 3826 | 0.090 |
Why?
| | Protein Kinase C-delta | 1 | 2009 | 80 | 0.090 |
Why?
| | Protein Structure, Secondary | 1 | 2009 | 388 | 0.090 |
Why?
| | Inflammation | 2 | 2014 | 2457 | 0.070 |
Why?
| | Protein Kinase Inhibitors | 1 | 2011 | 857 | 0.070 |
Why?
| | Thrombin | 2 | 2015 | 126 | 0.070 |
Why?
| | Thrombocytopenia | 2 | 2015 | 189 | 0.060 |
Why?
| | Benzothiazoles | 1 | 2020 | 42 | 0.050 |
Why?
| | Plasma | 1 | 2022 | 245 | 0.050 |
Why?
| | Freeze Drying | 1 | 2019 | 160 | 0.040 |
Why?
| | Coagulants | 1 | 2018 | 9 | 0.040 |
Why?
| | Binding, Competitive | 1 | 2018 | 213 | 0.040 |
Why?
| | Male | 5 | 2018 | 60969 | 0.040 |
Why?
| | Protein Interaction Domains and Motifs | 1 | 2018 | 139 | 0.040 |
Why?
| | Thrombelastography | 1 | 2019 | 264 | 0.040 |
Why?
| | Infusions, Intravenous | 1 | 2018 | 406 | 0.040 |
Why?
| | Oxygen Consumption | 1 | 2019 | 660 | 0.040 |
Why?
| | Thrombopoiesis | 1 | 2015 | 6 | 0.040 |
Why?
| | Receptors, Purinergic P2Y12 | 1 | 2015 | 8 | 0.040 |
Why?
| | Lymphopenia | 1 | 2015 | 55 | 0.040 |
Why?
| | Splenectomy | 1 | 2015 | 51 | 0.040 |
Why?
| | Female | 4 | 2016 | 63296 | 0.030 |
Why?
| | Guanine Nucleotide Exchange Factors | 1 | 2015 | 64 | 0.030 |
Why?
| | Binding Sites | 1 | 2018 | 1292 | 0.030 |
Why?
| | Blood Coagulation Tests | 1 | 2014 | 56 | 0.030 |
Why?
| | Antithrombins | 1 | 2014 | 58 | 0.030 |
Why?
| | Cellular Senescence | 1 | 2015 | 147 | 0.030 |
Why?
| | Pulmonary Embolism | 1 | 2015 | 176 | 0.030 |
Why?
| | Protein Isoforms | 1 | 2014 | 356 | 0.030 |
Why?
| | Immunoprecipitation | 1 | 2013 | 176 | 0.030 |
Why?
| | src-Family Kinases | 1 | 2013 | 95 | 0.030 |
Why?
| | Adoptive Transfer | 1 | 2013 | 211 | 0.030 |
Why?
| | Proto-Oncogene Proteins c-akt | 1 | 2015 | 458 | 0.030 |
Why?
| | Hemophilia A | 1 | 2013 | 58 | 0.030 |
Why?
| | Cell Survival | 1 | 2016 | 1139 | 0.030 |
Why?
| | Mice, Inbred BALB C | 1 | 2015 | 1316 | 0.030 |
Why?
| | Receptors, G-Protein-Coupled | 1 | 2013 | 222 | 0.030 |
Why?
| | Phospholipase C gamma | 1 | 2010 | 26 | 0.030 |
Why?
| | Phosphoproteins | 1 | 2013 | 324 | 0.030 |
Why?
| | Receptor Protein-Tyrosine Kinases | 1 | 2013 | 277 | 0.020 |
Why?
| | Gene Knockout Techniques | 1 | 2010 | 118 | 0.020 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2013 | 387 | 0.020 |
Why?
| | Thromboxane A2 | 1 | 2009 | 14 | 0.020 |
Why?
| | Receptors, Proteinase-Activated | 1 | 2009 | 1 | 0.020 |
Why?
| | Protein Kinase C-theta | 1 | 2009 | 3 | 0.020 |
Why?
| | Qa-SNARE Proteins | 1 | 2009 | 17 | 0.020 |
Why?
| | Phenylalanine | 1 | 2009 | 62 | 0.020 |
Why?
| | Crystallization | 1 | 2009 | 159 | 0.020 |
Why?
| | Solubility | 1 | 2009 | 267 | 0.020 |
Why?
| | Adenocarcinoma | 1 | 2015 | 814 | 0.020 |
Why?
| | Pancreatic Neoplasms | 1 | 2015 | 728 | 0.020 |
Why?
| | Anticoagulants | 1 | 2013 | 539 | 0.020 |
Why?
| | Cell Line, Tumor | 1 | 2015 | 2891 | 0.020 |
Why?
| | Crystallography, X-Ray | 1 | 2009 | 467 | 0.020 |
Why?
| | Mice, Transgenic | 1 | 2013 | 2108 | 0.020 |
Why?
| | Mutation | 1 | 2018 | 3403 | 0.020 |
Why?
| | Oligopeptides | 1 | 2009 | 271 | 0.020 |
Why?
| | Antibodies | 1 | 2009 | 417 | 0.020 |
Why?
| | Amino Acid Sequence | 1 | 2009 | 2161 | 0.020 |
Why?
| | Gene Expression | 1 | 2010 | 1538 | 0.020 |
Why?
| | Peptide Fragments | 1 | 2009 | 736 | 0.020 |
Why?
| | Molecular Sequence Data | 1 | 2009 | 3014 | 0.020 |
Why?
| | Neoplasms | 1 | 2015 | 2079 | 0.010 |
Why?
| | Middle Aged | 1 | 2014 | 28958 | 0.010 |
Why?
|
|
Getz's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|